Private Advisor Group LLC Has $244,000 Position in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Private Advisor Group LLC boosted its holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 15.6% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,380 shares of the company’s stock after acquiring an additional 457 shares during the quarter. Private Advisor Group LLC’s holdings in Prestige Consumer Healthcare were worth $244,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in PBH. Ariel Investments LLC raised its holdings in shares of Prestige Consumer Healthcare by 10.7% in the 2nd quarter. Ariel Investments LLC now owns 2,835,203 shares of the company’s stock worth $195,204,000 after buying an additional 274,212 shares in the last quarter. Victory Capital Management Inc. grew its stake in Prestige Consumer Healthcare by 9.0% during the second quarter. Victory Capital Management Inc. now owns 2,074,460 shares of the company’s stock worth $142,827,000 after buying an additional 171,357 shares during the last quarter. Allspring Global Investments Holdings LLC increased its holdings in shares of Prestige Consumer Healthcare by 19.3% during the third quarter. Allspring Global Investments Holdings LLC now owns 1,575,170 shares of the company’s stock worth $113,570,000 after buying an additional 255,045 shares in the last quarter. The Manufacturers Life Insurance Company raised its stake in shares of Prestige Consumer Healthcare by 0.8% in the second quarter. The Manufacturers Life Insurance Company now owns 543,401 shares of the company’s stock valued at $37,413,000 after acquiring an additional 4,305 shares during the last quarter. Finally, Leeward Investments LLC MA boosted its holdings in shares of Prestige Consumer Healthcare by 5.6% in the 2nd quarter. Leeward Investments LLC MA now owns 406,093 shares of the company’s stock worth $27,960,000 after acquiring an additional 21,549 shares in the last quarter. Institutional investors own 99.95% of the company’s stock.

Prestige Consumer Healthcare Stock Up 3.1 %

Prestige Consumer Healthcare stock opened at $80.07 on Friday. The firm has a market capitalization of $3.97 billion, a price-to-earnings ratio of 19.58, a PEG ratio of 2.08 and a beta of 0.47. The company’s 50 day simple moving average is $72.43 and its 200 day simple moving average is $69.78. The company has a debt-to-equity ratio of 0.65, a current ratio of 3.23 and a quick ratio of 1.90. Prestige Consumer Healthcare Inc. has a fifty-two week low of $56.61 and a fifty-two week high of $81.25.

Prestige Consumer Healthcare (NYSE:PBH) last posted its earnings results on Thursday, August 8th. The company reported $0.90 earnings per share for the quarter, topping the consensus estimate of $0.86 by $0.04. Prestige Consumer Healthcare had a net margin of 18.43% and a return on equity of 12.55%. The company had revenue of $267.10 million for the quarter, compared to analyst estimates of $260.54 million. During the same period last year, the business posted $1.06 earnings per share. The business’s revenue for the quarter was down 4.4% compared to the same quarter last year. As a group, sell-side analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.43 EPS for the current year.

Analysts Set New Price Targets

PBH has been the topic of a number of recent analyst reports. Jefferies Financial Group reissued a “hold” rating and issued a $76.00 price objective (up previously from $70.00) on shares of Prestige Consumer Healthcare in a research note on Tuesday, September 24th. DA Davidson increased their price objective on shares of Prestige Consumer Healthcare from $93.00 to $95.00 and gave the stock a “buy” rating in a report on Wednesday, August 28th. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $94.20.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.